Correction
for
Horn et al., Ann Pharmacother 41 (4) 674-680.
Published Online, 2 September 2008, www.theannals.com, DOI 10.1345/aph.1K591c.
The Annals of Pharmacotherapy: Vol. 42, No. 10, pp. 1521. DOI 10.1345/aph.1K591c
© 2008 Harvey Whitney Books Company.
Correction: Aspirin, Clopidogrel, and Warfarin: Is the Combination Appropriate and Effective or Inappropriate and Too Dangerous?
Published Online, September 2, 2008. www.theannals.com, DOI 10.1345/aph.1K591c
In this article (2008;42:790-805), on page 793, column 2, the penultimate
sentence should appear without the phrase of the aforementioned
studies. It should read: "A recent meta-analysis found a higher
incidence of major bleeding in patients receiving aspirin and warfarin
compared with the incidence in patients receiving warfarin alone (OR 1.43 [95%
CI 1.00 to 2.02]).23" Second, reference 25, cited on
page 794, column 1, should be replaced with: Leon MB, Baim DS, Popma JJ, et
al. A clinical trial comparing three antithrombotic-drug regimens after
coronary-artery stenting. Stent Anticoagulation Restenosis Study
Investigators. N Engl J Med 1998;339:1665-71. Third, on page 794, column 1,
the sentence citing reference 26 should cite reference 13 instead.
Footnotes
Letters are subject to review prior to acceptance. They should address
areas related to pharmacy practice, research, or education, or articles
recently published. Corrections of previously published material also are
accepted. Letters are limited to no more than five authors. In cases where
adverse effects or drug interactions are described, the Naranjo ADR
probability scale (Clin Pharmacol Ther 1981;30:239-45) or DIPS scale (Ann
Pharmacother 2007;41:674-80. DOI
10.1345/aph.1H423), respectively, should be used to determine the likelihood
that the adverse effect or interaction was drug-related. Text: limit 500
words. References: limit 5. Art: limit 1 table or figure.
